Citryll
Treating Inflammatory Diseases
Citryll is a biotech company in Oss, Netherlands, founded in 2015. It has 1 recorded funding round, most recently a Series B in December 2024.
- Headquarters
- Oss, North Brabant
- Employees
- 11–50
- Founded
- 2015
- Website
- citryll.com
- Last Round
- Series BDec 2024
- Rounds
- 1
Indexed holds 1 funding round and 4 investors for this company. to use credits for reveals, or explore the API.
About
Citryll develops therapies focused on rheumatoid arthritis and hidradenitis suppurativa. Its approach targets ETs by preventing new ones from forming and helping remove those already present. The combination of formation inhibition and enhanced clearance underpins its therapeutic strategy for these inflammatory diseases.
Funding History
Dec 2024
Investors
Tech & App Stack
4 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
- Backend ×2
- DevOps ×1
- Marketing & SEO ×1
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Companies in related industries
Neuralink develops investigational implantable brain-computer interfaces that help people with pa...
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...

Specialty pharmaceutical company
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/citryll"><img src="https://indexed.vc/api/badge/company/citryll" alt="Citryll on Indexed.vc" width="260" height="76" /></a>
